Apollo Therapeutics Ltd

This is an early safety study testing a new vaccine designed to protect against rhinovirus, a main cause of the common cold. Researchers will give the vaccine or a placebo to 144 healthy adults in Australia to check for side effects and see if it triggers an immune response. The …

This early-stage study is testing a new drug called APL-4098 in adults with advanced forms of blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Researchers want to find the safest dose and see how well the drug works when given alone or combined …

This early-stage study is testing a new drug called APL-5125 in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug can shrink tumors, especially in colorectal canc…

This study is testing whether APL-9796 injections are safe and might help control pulmonary hypertension, a serious condition where blood pressure in the lungs is dangerously high. The trial will involve 48 adults who already have a special heart sensor implanted to monitor their…